SEC Filings - MiNK Therapeutics

Form	Description	Filing date	View
5	Annual filing director officer or owner of more than ten percent.	Feb 14, 2022	View HTML 0000899243-22-006140.pdf 0000899243-22-006140.rtf 0000899243-22-006140.xls
ARS	An annual report to security holders	Apr 30, 2024	View HTML 0000950170-24-050088.pdf 0000950170-24-050088.rtf
SC 13D/A	An amendment to a SC 13D filing	May 03, 2023	View HTML 0001193125-23-134576.pdf 0001193125-23-134576.rtf 0001193125-23-134576.xls
SC 13D/A	An amendment to a SC 13D filing	May 26, 2023	View HTML 0001193125-23-155541.pdf 0001193125-23-155541.rtf 0001193125-23-155541.xls
DRS/A	Amendment to a previously filed DRS	Jul 28, 2021	View HTML 0000950123-21-009292.pdf 0000950123-21-009292.rtf 0000950123-21-009292.xls
DRS/A	Amendment to a previously filed DRS	Mar 18, 2021	View HTML 0000950123-21-003599.pdf 0000950123-21-003599.rtf 0000950123-21-003599.xls
4/A	Amendment to a previously filed 4	May 26, 2023	View HTML 0000950170-23-024556.pdf 0000950170-23-024556.rtf 0000950170-23-024556.xls
4/A	Amendment to a previously filed 4	May 26, 2023	View HTML 0000950170-23-024567.pdf 0000950170-23-024567.rtf 0000950170-23-024567.xls
4/A	Amendment to a previously filed 4	May 26, 2023	View HTML 0000950170-23-024568.pdf 0000950170-23-024568.rtf 0000950170-23-024568.xls
S-1/A	Amended Registration statement for face-amount certificate companies	Oct 12, 2021	View HTML 0001193125-21-296215.pdf 0001193125-21-296215.rtf 0001193125-21-296215.xls

Data provided by Kaleidoscope.